24СʱÈÈÃŰæ¿éÅÅÐаñ    

Znn3bq.jpeg
²é¿´: 571  |  »Ø¸´: 2

yolanda1234

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÃÀ¹úµÄÒ»¸öÐÂҩרÀû

±¾ÈËÔÚÉúÎï¹ÈÖп´µ½Ò»ÔòÏûÏ¢£¬Ô­ÎÄΪ£º2013Äê3ÔÂ5ÈÕѶ /ÉúÎï¹ÈBIOON/ --ÎäÌTakeda£©ÓëÃÀ¹úÉúÎï¼¼Êõ¹«Ë¾Resolve Therapeutics´ï³ÉÁ˺Ï×÷»ï°é¹ØÏµ£¬¹²Í¬¿ª·¢»¯ºÏÎÓÃÓÚÖÎÁƺì°ßÀÇ´¯¼°ÆäËû×ÔÉíÃâÒßÐÔ¼²²¡¡£Ïȵ¼»¯ºÏÎïRSLV-132ÊÇÒ»ÖÖºËøFcÈںϵ°°×£¬Äܹ»½µ½â²¢Çå³ýº¬ÓÐ×ÔÉí¿¹ÌåµÄÃâÒ߸´ºÏÎ˫·½½«ÔÚ½ñÄêÍíЩʱÆÚÆô¶¯¸Ã»¯ºÏÎïµÄÁÙ´²¿ª·¢¡£´ËÍ⣬»¹ÓÐÊýÖÖ»¯ºÏÎï´¦ÓÚÁÙ´²Ç°µÄ¸ÅÄîÑéÖ¤½×¶Î¡££¨ÉúÎï¹Èbioon.com£©
ÏêϸӢÎı¨µÀ£º
The lead compound, RSLV-132, is a nuclease Fc fusion protein that degrades and eliminates autoantibody-containing immune complexes, which are thought to be the most proximal pathophysiological trigger of lupus. It will begin clinical development later this year. Additional Resolve clinical candidates are in the pre-clinical proof-of-concept stage.
Resolve will conduct all development work under the collaboration until completion of the first RSLV-132 Phase 1b/2a trial in lupus patients. Takeda has the exclusive option to license the lead compound and all other compounds from the Resolve platform upon the completion of the Phase 1b/2a trial. Upon exercise of its option, Takeda would assume lead responsibility for worldwide development and commercialization of the Resolve products.
Under the terms of the agreement, Takeda will help fund continued development of RSLV-132 through an initial payment of US$8 million to Resolve in fiscal 2012. Upon exercise of its option, Takeda would pay Resolve an option exercise fee, plus the potential for additional development milestones totaling US$247 million. Furthermore Resolve is eligible to receive royalties on product sales.
¹Ø¼ü´Ê£º ÎäÌï ºì°ßÀÇ´¯
ÇóÕâ¸öRSLV-132µÄרÀûÔ­ÎÄ¡£¡£¡£¡£¡£¡£¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÐÂÊÖÉÏ·£¬Ð¡Ä¾³æ£¬ÎҵĿÆÑаéÂÂ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wjswift

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¿´ÎÄÏ×£¬×öʵÑé......

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
yolanda1234: ½ð±Ò+30, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ÆäʵÊÇÎÒÏëÖªµÀÕâ¸ö¿ìѶÊÇ·ñÊÇÕæµÄ£¬Ð»Ð»Ä㣬Õâô¿ì¾Í¸øÎһظ´ÁË¡£»¹ÓÐÎÊÌâÏëÎÊÂ¥Ö÷Ŷ¡£Õâ¸öÒ©£¬Èç¹ûͶÈëÊг¡»¹Òª¶à¾Ã£¿ 2013-03-08 17:17:08
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2013-03-09 08:01:27
US20120225066
CN102770533
http://1000eb.com/gksl

¸Ð¾õlzÇóÖúµÄ¶«Î÷ºÍÌîµÄרҵ²»´î°¡£¬ÕæÊÇÉæÁԹ㷺¡£¡£¡£
Darwin said, a scientific man ought to have no wishes, no affections, - a mere heart of stone.
2Â¥2013-03-08 11:52:38
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jinlong3820

½ð³æ (ÖøÃûдÊÖ)

ÒýÓûØÌû:
2Â¥: Originally posted by wjswift at 2013-03-08 11:52:38
US20120225066
CN102770533
http://1000eb.com/gksl

¸Ð¾õlzÇóÖúµÄ¶«Î÷ºÍÌîµÄרҵ²»´î°¡£¬ÕæÊÇÉæÁԹ㷺¡£¡£¡£

²»ÓÃÄÇôÔÚÒâµÄ£¬Ëæ±ãд¸ö¾ÍºÃÁË£¬Äú¾õµÃÁË£¿
Stayhungry£¬stayfoolish£¡Ò»¸ö²»ÖªµÀºó»ÚµÄ±¿µ°|| ƽµ­ÖиøÄ㾪ϲ£¡
3Â¥2013-03-09 10:37:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ yolanda1234 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 293Çóµ÷¼Á +12 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 13/650 2026-04-12 21:32 by wangluhui
[¿¼ÑÐ] 268·Ö085602»¯Ñ§¹¤³Ìµ÷¼Á +30 ÔÂÕÕ»¨ÁÖ¡£ 2026-04-09 30/1500 2026-04-12 19:17 by laoshidan
[¿¼ÑÐ] µçÆø¹¤³Ìר˶320Çóµ÷¼Á +5 СÂé×Ó111 2026-04-10 5/250 2026-04-12 10:47 by zhouyuwinner
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤300Çóµ÷¼Á +39 Ф¿ªÎÄ 2026-04-09 43/2150 2026-04-12 01:30 by Çï¶¹²ËÑ¿
[¿¼ÑÐ] 22ר˶Çóµ÷¼Á +6 haoyunÉϰ¶ 2026-04-11 8/400 2026-04-11 23:21 by labixiaoqiao
[¿¼ÑÐ] 269µç×ÓÐÅÏ¢Çóµ÷¼Á£¬¿Éתרҵ +11 ¶À×Ãwl 2026-04-06 11/550 2026-04-11 11:12 by ÄæË®³Ë·ç
[¿¼ÑÐ] Ò»Ö¾Ô¸985»úеѧ˶380Çóµ÷¼Á +5 ¹Ø¹ØöÂð¯10 2026-04-11 5/250 2026-04-11 10:10 by ÖªÄî¡£A
[¿¼ÑÐ] 297Çóµ÷¼Á +9 Kwgyz 2026-04-09 9/450 2026-04-11 10:09 by zhq0425
[¿¼ÑÐ] 22408 352·ÖÇóµ÷¼Á0854Àà +4 ŬÁ¦µÄÏÄÄ© 2026-04-09 4/200 2026-04-11 09:57 by zhq0425
[¿¼ÑÐ] »úеר368 ÓÐÈ¥´¦Âð +4 ÖÖ´óÊ÷ 2026-04-10 4/200 2026-04-10 15:31 by jiajinhpu
[¿¼ÑÐ] 282£¬µçÆø¹¤³Ìרҵ£¬Çóµ÷¼Á£¬²»Ìôרҵ +9 jggshjkkm 2026-04-10 9/450 2026-04-10 14:55 by ÄæË®³Ë·ç
[¿¼ÑÐ] 284Çóµ÷¼Á +7 ÈÃÎÒÉϰ¶°É°¢Î÷ 2026-04-09 7/350 2026-04-09 18:59 by haironglove
[¿¼ÑÐ] 085400µç×ÓÐÅÏ¢Àࣨ´¨´ó¿ØÖƹ¤³Ì£©Çóµ÷¼Á¿É¿çרҵ ÇóÀÏʦÁªÏµ +3 626776879 2026-04-08 3/150 2026-04-09 16:05 by Öí»á·É
[¿¼ÑÐ] 349ѧ¿Æ»¯Ñ§045106Çóµ÷¼Á£¬»¯Ñ§Àà¶¼¿ÉÒÔ +8 ±£ºÃ¶®¶® 2026-04-08 8/400 2026-04-09 14:03 by xulei3024
[¿¼ÑÐ] 307Çóµ÷¼Á +14 ³¬¼¶ÒÁ°º´óÍõ 2026-04-06 14/700 2026-04-08 07:03 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Çóµ÷¼Á +11 wwwwabcde 2026-04-07 11/550 2026-04-07 23:16 by JourneyLucky
[¿¼ÑÐ] 331Çóµ÷¼Á +5 ÕÅÔªÒ» 2026-04-07 6/300 2026-04-07 22:13 by hemengdong
[¿¼ÑÐ] 312Çóµ÷¼Á +18 gtw1 2026-04-06 20/1000 2026-04-07 18:16 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 22408 µ÷¼Á²ÄÁÏ +7 ÎÒ½Ðez 2026-04-06 8/400 2026-04-07 17:12 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 071000ÉúÎïѧµ÷¼Á +7 À­ÌáÌÒ 2026-04-06 7/350 2026-04-06 18:55 by 52305043001
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û